eprintid: 10106636
rev_number: 18
eprint_status: archive
userid: 608
dir: disk0/10/10/66/36
datestamp: 2020-08-07 15:38:15
lastmod: 2021-12-06 00:51:07
status_changed: 2020-08-07 15:38:15
type: article
metadata_visibility: show
creators_name: Alwafi, H
creators_name: Wong, ICK
creators_name: Banerjee, A
creators_name: Mongkhon, P
creators_name: Whittlesea, C
creators_name: Naser, AY
creators_name: Lau, WCY
creators_name: Wei, L
title: Epidemiology and treatment of atrial fibrillation in patients with type 2 diabetes in the UK, 2001–2016
ispublished: pub
divisions: UCL
divisions: B02
divisions: C08
divisions: D10
divisions: G11
divisions: DD4
keywords: Arrhythmias, Diabetes, Epidemiology
note: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
abstract: Patients with Type 2 diabetes mellitus (T2DM) have an increased risk of atrial fibrillation (AF). The current study aimed to investigate the prevalence and treatment of AF in patients with T2DM, assess the impact of direct oral anticoagulants (DOACs) introduction on oral anticoagulant (OACs) prescribing rates, and factors associated with OAC initiations in patients with T2DM and AF. The Health Improvement Network (THIN) database (2001–2016), was used to examine the annual prevalence and treatment of AF in T2DM. The impact of DOACs introduction on OAC prescribing rates were investigated using interrupted time series analysis (ITS). Factors associated with OAC initiations were also identified using multivariate logistic regression. The prevalence of AF increased from 2.7 [95% confidence intervals (CI) 2.5–2.8] in 2001 to 5.0 (4.9–5.1) in 2016 per 100 persons. OACs prescribing within 30-days of AF diagnosis increased from 21.5% in 2001 to 56.8% in 2016. ITS analysis showed that OAC prescribing increased after DOAC introduction (P < 0.001), however, no immediate change was observed (P = 0.29). T2DM patients with AF, aged 60–79, male gender and BMI ≥ 25 were more likely to receive OAC, adjusted OR 1.3 (1.2–1.5) for aged 60–79, 1.3 (1.2–1.4) for male gender and 2.0 (1.9–2.2) for BMI ≥ 25, respectively. This study highlighted an increase in prevalence of AF in patients with T2DM during the study period. Further studies are warranted to investigate factors contributing to the underuse of OAC in patients with T2DM and AF.
date: 2020-07-27
date_type: published
official_url: https://doi.org/10.1038/s41598-020-69492-z
oa_status: green
full_text_type: pub
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1800996
doi: 10.1038/s41598-020-69492-z
pii: 10.1038/s41598-020-69492-z
lyricists_name: Banerjee, Amitava
lyricists_name: Lau, Cheuk Yin
lyricists_name: Wei, Li
lyricists_name: Whittlesea, Catherine
lyricists_name: Wong, Ian
lyricists_id: ABANE83
lyricists_id: CYLAU57
lyricists_id: LWEIX32
lyricists_id: CWHIA33
lyricists_id: ICKWO00
actors_name: Wong, Ian
actors_name: Harris, Jean
actors_id: ICKWO00
actors_id: JAHAR68
actors_role: owner
actors_role: impersonator
full_text_status: public
publication: Scientific Reports
volume: 10
article_number: 12468
event_location: England
citation:        Alwafi, H;    Wong, ICK;    Banerjee, A;    Mongkhon, P;    Whittlesea, C;    Naser, AY;    Lau, WCY;           Alwafi, H;  Wong, ICK;  Banerjee, A;  Mongkhon, P;  Whittlesea, C;  Naser, AY;  Lau, WCY;  Wei, L;   - view fewer <#>    (2020)    Epidemiology and treatment of atrial fibrillation in patients with type 2 diabetes in the UK, 2001–2016.                   Scientific Reports , 10     , Article 12468.  10.1038/s41598-020-69492-z <https://doi.org/10.1038/s41598-020-69492-z>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10106636/1/s41598-020-69492-z.pdf